From our friends at Treatment Magazine
When the CEOs of the nation’s two largest addictions treatment enterprises, on the for-profit side Andy Eckert of CRC Health Corp. and on the non-profit side Mark Mishek of Hazelden, step up with strong views on what they see as the limited prospects for growth on the residential/inpatient side, it’s certainly time for the rest of the industry to sit up and take notice,In a wide ranging interview with Treatment Magazine in early December, CRC’s Andy Eckert made clear that the payors were pretty much fed up with what they see as an increasing revolving door when it comes to primary care residential treatment. “The commercial insurers do not see value in terms of better outcomes in spending money funding endless residential primary care experiences,” says Eckert, pointing out that payors have recently approached CRC about starting a number of IOP and PHP programs linked to the detoxification and maintenance services delivered at CRC’s nationwide network of opiate specialty clinics, now by far the largest after CRC’s $58M deal to acquire the 22 Northeast opiate centers of Boston-based Habit OPCO.
Read more here.
Comments